Hepatoprotective and antiviral functions of silymarin components in hepatitis C virus infection

Authors

  • Stephen J. Polyak,

    Corresponding author
    1. Department of Laboratory Medicine, University of Washington, Seattle, WA
    2. Department of Microbiology, University of Washington, Seattle, WA
    3. Department of Global Health, University of Washington, Seattle, WA
    • Virology 359690, 325 9th Ave., Seattle, WA, 98104
    Search for more papers by this author
    • fax: 206-897-4312

  • Peter Ferenci,

    1. Medical University of Vienna, Austria
    Search for more papers by this author
  • Jean-Michel Pawlotsky

    1. National Reference Center for Viral Hepatitis B, C and Delta, Department of Virology, Henri Mondor Hospital, University of Paris-Est, Créteil, France
    2. INSERM U955, Créteil, France
    Search for more papers by this author

  • Potential conflict of interest: Dr. Pawlotsky advises Rottapharm Madaus. Dr. Ferenci consults for, advises, is on the speakers' bureau of, and received grants from Rottapharm Madaus.

  • S.J.P. is partially supported by NIH grant R01AT006842, U19AI066328, and R56AI091840. J.M.P. is supported by Agence Nationale de Recherche sur le SIDA et les Hépatites Virales (ANRS), Institut National de la Santé et de la Recherche Médicale (INSERM) and Fondation pour la Recherche Médicale (FRM).

Ancillary